Reporting Avenues for Concerns Related to Integrity or Fairness

The recurring SBIR special emphasis panel, Small Business: Health Services and Systems (HSS 10) reviews applications that propose technologies to improve health service delivery, management, and quality and that provide digital health approaches to improve provision of health care services by providers, healthcare organizations, and insurers. Technologies include those that use large scale clinical or bioinformatic data to predict, diagnose, screen, or provide surveillance or data visualization for a range of diseases and health conditions.

Review Dates

Topics


  • Technologies and approaches designed to improve or inform health policy, such as more cost-effective, more accessible, and/or higher quality services to improve health care and delivery.
  • Tools that utilize clinical and bioinformatic data and/or biostatistical approaches (e.g., data mining of EHR data, analytics, natural language processing, machine learning, computer visualization) for use in clinical practice and clinical decision support (e.g., dashboards) across a wide range of disease conditions.
  • Approaches such as mHealth and biosensor technology for clinical use and implemented in clinical settings (e.g., hospitals, ERs, long-term care settings, primary care, etc.).
  • Products designed to improve dissemination and implementation of tools and technologies and that allow movement of research evidence into practice across various settings are also reviewed in HSS 10. The “science of clinical trials” applications are included in HSS 10.

Shared Interests and Overlaps

There are shared interests between Small Business: Biobehavioral Process study section (BP 10) and HSS 10 in the study of prediction and diagnosis of psychopathological, neurodevelopmental, and related conditions. Applications that propose the development of tools that address individual risk factors and change human behavior to prevent, treat, or improve recovery from disease are reviewed in BP 10. Technologies that provide large scale screening, provide surveillance, and target service delivery in healthcare settings are reviewed in HSS 10.

There are shared interests between Small Business: Clinical Care and Health Interventions study section (CCHI 10) and HSS 10 in the study of ways to improve care and delivery and monitoring of disease. Applications that propose tools to address individual risk factors and seek to change human behavior to prevent, treat, or improve recovery from disease are reviewed in CCHI 10. Technologies that provide large scale screening, provide surveillance, and target service delivery in healthcare settings are reviewed in HSS 10.

There are shared interests between Small Business: Social and Community Influences across the Lifecourse (SCIL 10) and HSS 10 in the study of interventions to promote health and management of disease conditions. Applications that address or target dyadic, family, school, neighborhood, and community-based organizations level are reviewed in SCIL 10, while applications that focus on interventions delivered within the context of health care settings are reviewed in HSS 10.

There are shared interests between Small Business: Molecular and Cellular Sciences and Technologies (MCST 14) and HSS 10 in the study of technological methods that involve computational, biostatistical, and biomedical datasets. Applications are reviewed in MCST 14 if the dominant focus is on computational and mathematical sciences, imaging analysis methods, and system biology. Applications are reviewed in HSS 10 if they involve development or refinement of a statistical or technological method for clinical decision support.

There are shared interests between Small Business: Musculoskeletal, Skin, and Oral Sciences (MSOS 10) and HSS 10 in the study of musculoskeletal, oral, and dermatological health. Applications are reviewed in MSOS 10 if the aims involve treatment strategies for musculoskeletal, dental, and skin diseases or disorders, including rehabilitation strategies, orthopedic procedures, implants, assistive technologies, and prosthetic devices. Applications are reviewed in HSS 10 if the aims relate to utilizing the technology to improve the provision of health services and delivery by care providers and in clinical settings.

There are shared interests between the small business panels in the Imaging, Surgery, and Bioengineering Review Branch (ISB) and HSS 10 in the study of medical sensing devices. Applications are reviewed in ISB if the aims focus on advanced development and design of biomedical sensing technologies, devices and systems in the context of healthcare and clinical use. Applications are reviewed in HSS 10 if the aims involve the use of large-scale clinical and bioinformatic data to develop technologies for use in clinical practice and clinical decision-support.

There are shared interests between the small business panels in the Endocrine and Metabolic Systems Review Branch (EMS) and HSS 10 in the study of disorders related to metabolic and reproductive systems (diabetes, reproductive aging and menopause, obstetrics, neonatology, etc.). Applications are reviewed in EMS if the aims focus on improved therapeutic strategies and bio-engineering approaches for monitoring and studying these disorders. Applications are reviewed in HSS 10 if the aims focus on implementation of the approach in clinical practice or for use in clinical decision support.

There are shared interests between the small business panels in the Kidney, Urology, and Digestive Systems Review Branch (KUDS) and HSS 10 in the study of disorders of digestive, kidney, and urological sciences. Applications that focus on development and evaluation of new techniques, therapies, and treatments are reviewed in KUDS. Applications whose aims focus on implementation of the approach in clinical practice or for use in clinical decision support are reviewed in HSS 10.